Galapagos NV (GLPG)
Market: NASD |
Currency: USD
Address: Generaal De Wittelaan L11 A3
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.Ã r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Show more
📈 Galapagos NV Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$31.73
-
Upside/Downside from Analyst Target:
12.43%
-
Broker Call:
-1
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
0-10%
-
Net Income Growth Range (1Y):
0-10%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Galapagos NV
| Date | Reported EPS |
|---|
| 2025-10-22 (estimated upcoming) | - |
| 2025-10-21 (estimated upcoming) | - |
| 2025-07-23 (estimated upcoming) | - |
| 2025-07-22 (estimated upcoming) | - |
| 2025-04-23 | -2.33 |
| 2025-04-23 | - |
| 2025-04-22 | - |
| 2025-02-12 | 0.38 |
| 2024-10-30 | -0.77 |
| 2024-08-01 | 0.14 |
| 2024-07-31 | 0.14 |
| 2024-05-02 | 1.4 |
| 2024-05-01 | 1.4 |
| 2024-02-22 | 2.39 |
| 2024-02-21 | 2.39 |
| 2023-11-02 | 0.39 |
| 2023-11-01 | 0.39 |
| 2023-08-03 | 0.08 |
| 2023-08-02 | 0.08 |
| 2023-05-04 | - |
| 2023-05-03 | - |
| 2023-02-23 | -3.16 |
| 2023-02-22 | -3.16 |
| 2022-11-03 | 0.33 |
| 2022-11-02 | 0.33 |
| 2022-08-04 | -0.29 |
| 2022-08-03 | -0.29 |
| 2022-05-05 | -0.2 |
| 2022-05-04 | -0.2 |
| 2022-02-24 | 0.25 |
| 2022-02-23 | 0.25 |
| 2021-11-04 | -0.99 |
| 2021-11-03 | -0.99 |
| 2021-08-05 | -0.98 |
| 2021-08-04 | -0.98 |
| 2021-05-06 | 0.14 |
| 2021-05-05 | 0.14 |
| 2021-02-18 | -0.88 |
| 2021-02-17 | -0.88 |
| 2020-11-05 | -1.25 |
| 2020-11-04 | -1.25 |
| 2020-08-06 | -1.77 |
| 2020-08-05 | -1.77 |
| 2020-05-06 | -0.78 |
| 2020-02-20 | -2.1 |
| 2020-02-19 | -2.1 |
| 2019-10-24 | 6.03 |
| 2019-10-23 | 6.03 |
| 2019-07-24 | -0.86 |
| 2019-04-24 | -0.89 |
| 2019-02-20 | 0.27 |
| 2018-10-23 | 0.28 |
| 2018-08-01 | -0.42 |
| 2018-04-24 | -0.73 |
| 2018-02-22 | -0.59 |
| 2017-10-29 | -0.72 |
| 2017-07-27 | -0.74 |
| 2017-04-26 | -0.29 |
| 2017-02-23 | 1.01 |
| 2016-10-26 | -0.52 |
| 2016-07-27 | -0.08 |
| 2016-04-28 | -0.48 |
| 2016-03-03 | -0.68 |
| 2015-11-12 | -0.72 |
| 2015-08-05 | -0.59 |
| 2015-03-05 | - |
📰 Related News & Research
No related articles found for "galapagos nv".
